Current Opinion in Chemical Biology is a systematic review journal that aims to provide specialists with a unique and educational platform to keep up to date with the expanding volume of information published in the field of Chemical Biology. The journal publishes 6 issues per year covering the following 10 sections, each of which is reviewed once a year, these are: Omics, Biocatalysis and Biotransformation, Bioinorganic Chemistry, Next Generation Therapeutics, Molecular Imaging, Chemical Genetics and Epigenetics, Synthetic Biology, Synthetic Biomolecules and Mechanistic Biology. There is also a section that changes regularly to reflect hot topics in the field. Current Opinion in Chemical Biology builds on Elsevier's reputation for excellence in scientific publishing. It is a companion to the new Gold Open Access journal Current Research in Chemical Biology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy of editorial excellence, high-impact, and global reach to ensure they are a widely read resource that is integral to scientists' workflow. Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal. Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience. Ethics in Publishing: General Statement - The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. For more information, please refer to https://www.elsevier.com/conflictsofinterest Benefits to authors - We also provide many author benefits, such as a customized Share Link providing 50 days free access to the final published version of the article on ScienceDirect, a liberal copyright policy, special discounts on Elsevier publications and much more.